VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+26.14%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$192M
AUM Growth
+$192M
(+3.5%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-171.88%
Top 10 Holdings %
Top 10 Hldgs %
91.02%
Holding
20
New
3
Increased
–
Reduced
8
Closed
4
Top Buys
1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$6.7M |
2 |
Xencor
XNCR
|
$1.04M |
3 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$571K |
Top Sells
1 |
Heron Therapeutics
HRTX
|
$290M |
2 |
Ironwood Pharmaceuticals
IRWD
|
$11.1M |
3 |
Vanda Pharmaceuticals
VNDA
|
$8.92M |
4 |
Neurocrine Biosciences
NBIX
|
$6.3M |
5 |
DYAX
DYAX CORPORATION
DYAX
|
$5.26M |
Sector Composition
1 | Healthcare | 61.66% |